New EULAR/ACR criteria help stratify RA risk in patients with arthralgia. Learn how these criteria guide earlier interventions & improve trial rigor.
Rheuminations: Address Ableism, Improve Care for All Patients
Ableism—discrimination against those with disabilities—distorts diagnostic reasoning & erodes patient trust. How can rheumatologists address this bias?
President’s Corner: Reflections on the ACR’s 2025
Dr. Langford’s final column reflects on 2025’s advocacy, challenges & member teamwork. Click through to read the outgoing ACR president’s parting thoughts.
Meet New ACR President William (Will) F. Harvey
Incoming ACR President Will Harvey shares his strategy for fighting reimbursement cuts, funding threats & workforce shortages through advocacy & member engagement.
Meet Incoming ARP President Rebecca Cleveland
Incoming ARP President Dr. Rebecca Cleveland discusses her plans for advocacy, ACR/ARP collaboration, & tackling workforce shortages in rheumatology.
Doctor with Lupus Models Hope & Resilience for Her Patients
From educating her colleagues to sharing stories of hope & words of encouragement with her patients, pediatric rheumatology resident Adaobi Ugochukwu draws on her own experience with lupus to ensure that patients receive empathetic, compassionate care.
A Liquid Biopsy for Lupus Nephritis?
Urine biomarkers have the potential to change how lupus nephritis is managed, serving as a noninvasive means of early detection, assessing treatment response and more.
The 2025 ACR Awards of Distinction
The ACR honors excellence in rheumatology. Meet the 2025 Awards of Distinction recipients, ACR Masters & Distinguished Fellows recognized at ACR Convergence 2025.
The 2025 ARP President’s & Merit Awards
Meet the 2025 ARP President’s & Merit Award recipients honored for their significant contributions to rheumatology research, education & patient care.
The ACR Names 16 New Masters
The ACR recognizes 16 members with its highest honor. See the 2025 class of ACR Masters & read their personal reflections on this career milestone.
ACR Honors Distinguished Fellows: Class of 2025
Meet the 10 clinical & research fellows named 2025 ACR Distinguished Fellows. Learn what this prestigious honor means to them & their work.
ACR Delegates Prepare for Fall Season Advocacy with the AMA
The ACR’s delegation to the American Medical Association’s House of Delegates is gearing up for the HOD Interim Meeting, slated for Nov. 14–18. Several members share their views on the value of this advocacy work and top issues this fall.
AHIP Confirms Continued Coverage of ACIP-Recommended Vaccines Through End of 2026
All vaccines recommended by the CDC’s ACIP as of Sept. 1, 2025—including updated COVID-19 and influenza shots—will be covered by health plans with no cost sharing for patients through the end of 2026.
2024 Traditional MIPS & MVP Final Scores Now Available
MIPS-eligible clinicians should review their scores to confirm performance. Any scoring concerns can be addressed through a targeted review
Oral Treatment for PsA Inches Closer to FDA Approval
The FDA will consider a supplemental new drug application for deucravacitinib for the treatment of adults with active psoriatic arthritis based on promising results from clinical trials.
New FDA Label Requirements for Opioids
After reviewing data from post-marketing observational studies, the FDA has issued new labeling requirements for opioids with the goal of emphasizing and explaining the risks associated with long-term use.